This is a federal contract award from the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit contract research organization and division of the Illinois Institute of Technology. The $2,037,052.00 cost-plus-fixed-fee contract was awarded on June 12, 2024 and has a completion date of June 11, 2026. The contract is for toxicology studies in mice and dogs administered MTX-531. IITRI has extensive experience supporting federal drug development efforts through both prime contracts and subcontracts with agencies such as NCI, NIAID, NINDS, and NCATS. This award is not associated with a set-aside designation. The parent organization, Illinois Institute of Technology, holds several significant IDIQ contract vehicles with federal agencies to efficiently provide specialized preclinical research services across multiple therapeutic areas.
Generated 3/20/25, 9:58 AM